Cargando…
Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116480/ https://www.ncbi.nlm.nih.gov/pubmed/30157957 http://dx.doi.org/10.1186/s13075-018-1651-7 |
| _version_ | 1783351616467894272 |
|---|---|
| author | Thai, Thuy Nhu Dawwas, Ghadeer K. |
| author_facet | Thai, Thuy Nhu Dawwas, Ghadeer K. |
| author_sort | Thai, Thuy Nhu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6116480 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61164802018-10-02 Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” Thai, Thuy Nhu Dawwas, Ghadeer K. Arthritis Res Ther Letter BioMed Central 2018-08-29 2018 /pmc/articles/PMC6116480/ /pubmed/30157957 http://dx.doi.org/10.1186/s13075-018-1651-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Thai, Thuy Nhu Dawwas, Ghadeer K. Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” |
| title | Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” |
| title_full | Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” |
| title_fullStr | Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” |
| title_full_unstemmed | Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” |
| title_short | Comments on the article “Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” |
| title_sort | comments on the article “effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study” |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116480/ https://www.ncbi.nlm.nih.gov/pubmed/30157957 http://dx.doi.org/10.1186/s13075-018-1651-7 |
| work_keys_str_mv | AT thaithuynhu commentsonthearticleeffectivenessandsafetyoftofacitinibinrheumatoidarthritisacohortstudy AT dawwasghadeerk commentsonthearticleeffectivenessandsafetyoftofacitinibinrheumatoidarthritisacohortstudy |